S1 Versus Capecitabine in the First Line Treatment of Metastatic Colorectal Cancer Patients, the SALTO Randomised Phase III Study of the Dutch Colorectal Cancer Group. A Safety Evaluation of Oral Fluoropyrimidines
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Bevacizumab; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms SALTO
- 15 Aug 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016.
- 15 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 27 Jan 2014 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015 according to ClinicalTrials.gov record.